Open Label Non- Controlled Exploratory Study of the Efficacy, Practicability and Safety of Intravenous Iron Supplementation Therapy in Moderate to Severe Restless Legs Syndrome With Iron Deficiency (Ferritin<35ug/l) or Anaemia (< 11 g/dl) in the 3rd Trimester of Pregnancy.

Trial Profile

Open Label Non- Controlled Exploratory Study of the Efficacy, Practicability and Safety of Intravenous Iron Supplementation Therapy in Moderate to Severe Restless Legs Syndrome With Iron Deficiency (Ferritin<35ug/l) or Anaemia (< 11 g/dl) in the 3rd Trimester of Pregnancy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Ferric carboxymaltose (Primary)
  • Indications Pregnancy; Restless legs syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 31 May 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 06 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top